Depletion of CD8+ T cells dramatically enhances the tumor growth and liver metastasis in CCL5−/− mice, compared to the isotype Ab treatment group, and their antitumor activity of CCL5-deficiency in CRC was lost (Fig. 2c, d). Here, CCL5 is linked to colorectal carcinoma.